Benefits Selective activation of melanocortin-1 receptors: Melanotan I has been studied for its selective activation of MC1R receptors located on melanocytes
In the landmark, large clinical studies of both semaglutide and tirzepatide for weight loss, participants took 1.7 or 2.4 mg of semaglutide and 5, 10, or 15 mg of tirzepatide
This is exactly what you would expect from a drug whose cardiac effects are driven by receptor activation, more drug means more receptor binding means more cAMP means faster heart rate
Based on current study guidelines, ideal candidates for this class of medication typically include: Individuals with Obesity or Overweight: Those who have a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 or higher with weight-related health conditions
They function specifically by inhibiting the Vitamin K Epoxide Reductase (VKOR) enzyme, effectively inducing a localized Vitamin K deficiency to slow down the liver's production of clotting factors